AUS
NZ
UK
CA
USA
IND
Summary
- Canada’s Ryah Medtech, Inc., teams up with Medical Kiwi Ltd for the distribution of RYAH Smart Inhaler and cloud-based data analytics platform across New Zealand.
- It would be a mutually rewarding experience for both the companies, thereby benefitting from the international clinical and distribution network.
- Last month, Medical Kiwi’s listing proposal was declined by the NZX.
In a major announcement, Ryah Medtech, Inc, a subsidiary of RYAH Group Inc. (CSE:RYAH), has entered into a partnership with New Zealand-based Medical Kiwi Ltd.
Source: Copyright © 2021 Kalkine Media
Ryah Medtech Signs An Agreement With Medical Kiwi
The agreement, which came into effect from 5 April 2021, enables the supply of RYAH Smart Inhaler and cloud-based data analytics platform throughout New Zealand. This partnership would benefit Ryah Medtech from the already established Medical Kiwi’s distribution network in Kiwiland.
Must Read: Another Medical Cannabis Firm To List On NZX
Moreover, both the companies would work in their respective field of expertise and draw mutual benefits through improvised medical patient care, as well as pre-clinical and clinical trial settings.
Must Read: Medicinal cannabis industry in NZ is set to boom despite hurdles
Gregory Wagner, RYAH Medtech, Inc's CEO, opined that through this agreement, both RYAH Medtech and Medical Kiwi would work towards innovation and deliver the most advanced plant-based medical solutions in Aotearoa.
It is pointed out that the Kiwi Government, in December 2019, passed a legislation for better access to medical cannabis products that had therapeutic benefits and were used in various alternative therapies.
All About RYAH Group, Inc
RYAH Group is a leading technology company, which focuses on IoT device and digital care platform, thereby enabling doctors, clinics, and other healthcare users to build upon customised dosing regimens.
It aims to bring revolutionary changes in patient care by way of using AI and big data and make headway in inventions, which will transform the understanding of the use of plant-based medicines.
About Medical Kiwi Ltd
Medical Kiwi Ltd is New Zealand’s leading medicinal company, which focuses on quality research, product development and distribution across NZ, as well as in the global markets. Ministry of Health has granted a Medicinal Cannabis licence to Medical Kiwi Ltd to grow, manufacture, as well as distribute medicinal cannabis.
Must Read: Medical Kiwi Not To Be listed On NZX For Now
Medical Kiwi Denied Listing On The NZX In April
In March this year, Medical Kiwi was planning to get itself listed on the NZX to provide an efficient Medical Kiwi share market options for the investors, as well as to increase awareness among people about medicinal cannabis.
However, it did not get the green signal of the New Zealand Stock Exchange and was investigated by the Financial Markets Authority on its capital raise of NZ$3 million in 2020.
FMA has directed Medical Kiwi to work on a sophisticated operating model. The latter is constantly in touch with NZ RegCo, the NZX regulator and is working towards getting itself listed on the NZX.
